Project Details
Description
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients with Progressive Supranuclear Palsy
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/15 → 7/31/18 |
Funding
- BRISTOL-MYERS SQUIBB PHARM RES
- BRISTOL-MYERS SQUIBB COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.